Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 702
Selected: 0
NCT IDTitle
NCT00589927Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent
NCT03287505Aripiprazole IM Depot for Chinese Patients With Schizophrenia
NCT04313153Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)
NCT00545675Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
NCT02336347A Phase 1 Study Comparing AVP-786 With AVP-923
NCT01663532Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
NCT05712746Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.
NCT01973140Effects of Tolvaptan in Healthy Adults
NCT07461220Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
NCT03643159A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
NCT02009878A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
NCT03605849A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
NCT02105285Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT00234104A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)
NCT02174835A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers
NCT00615589Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen
NCT00304616SWitching to Abilify Trial (SWAT)
NCT01782833Pletaal SR Post Marketing Observational Study
NCT03487783Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
NCT01074294Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
NCT00544869A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)
NCT00095810Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease
NCT01744808A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020
NCT03158324Phase IIa Dose-Expansion and Biomarker Study of OPB-111077
NCT05428033A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)
NCT01439009Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients
NCT02968121Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia
NCT04838639Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects
NCT02192554Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
NCT01050530A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema
NCT07525960A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body
NCT00216749Efficacy and Safety of Cilostazol for the Indication of CSPS
NCT06799520A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)
NCT00361790Aripiprazole and Lexapro Drug Interaction Study
NCT01393613Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
NCT01029509Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes
NCT07058233Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial
NCT03198078Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia
NCT00822172Evaluation of Cilostazol in Combination With L-Carnitine
NCT00823875Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject
NCT02446132Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT01981811Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
NCT01733134Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)
NCT01932203Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease
NCT03033069A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)
NCT02934932A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD
NCT03292848Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
NCT01779401Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
NCT01696617Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
NCT01475370Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)